St. Regis Mohawk Tribe v. Mylan Pharmaceuticals — Tribal Sovereign Immunity Does Not Bar IPR Proceedings
The Federal Circuit held that tribal sovereign immunity cannot be used to shield patents from inter partes review, rejecting a controversial licensing arrangement between Allergan and the St. Regis Mohawk Tribe designed to avoid IPR challenges to Restasis patents.